Study of Immunotoxin, MR1-1

Clinical trial NCT01009866 · TERMINATED

Trial details

NCT number

NCT01009866

Sponsor

Darell D. Bigner, MD, PhD

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2006-11-01

Primary completion

2012-12-01

Enrollment

9

View on ClinicalTrials.gov